Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-100
Closed -$40 – 3542
2023
Q1
$40 Buy
+100
New +$3.5K ﹤0.01% 3388
2022
Q1
– Sell
-10
Closed -$12K – 3517
2021
Q4
$12K Buy
+10
New +$520 ﹤0.01% 3147

Other funds holding GSK

HighTower Advisors's GSK Position: Q3 2026 in Review

HighTower Advisors increased its GSK (GSK) stake by 0.06% in Q3 2026, buying an estimated $3.88K and bringing the position to 118,336 shares worth $5.7M. The position accounts for 0.01% of the portfolio, ranked #1185.

HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $57.1M in Q1 2022. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • HighTower Advisors held 118,336 shares of GSK worth $5.7M as of Q3 2026.
  • HighTower Advisors bought 76 GSK shares in Q3 2026, an estimated $3.88K.
  • GSK made up 0.01% of HighTower Advisors's portfolio in Q3 2026, its #1185 holding.
  • HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's GSK position peaked at $57.1M in Q1 2022.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.